This paper addresses reliable control design for a switched system (SS) described by T-S fuzzy model subject to actuator failures and mode-dependent time-varying delay.
The aim of the addressed reliable passive control problem is to design a state feedback controller such that, for all possible actuator failures, the resultant closed-loop system is regular, impulse-free, exponentially stable, and passive.
The aim of the addressed reliable H∞ control problem is to design a controller such that, for the admissible infinite distributed delays and possible actuator failures, the closed-loop system is exponentially stable with a given disturbance attenuation level γ.
The aim of the addressed reliable tracking control problem is to design an observer-based controller, such that, for the admissible time-delays, uncertainties, unknown but bounded noises, quantization effects and actuator failures, both the tracking error and the estimation error are not more than certain upper bounds that can be minimized at each time instant.
The aim of the addressed reliable H∞ filtering problem is to design a filter such that, for all possible sensor failures, RONs, time-delays as well as admissible parameter uncertainties, the filtering error dynamics is asymptotically mean-square stable and also achieves a prescribed H∞ performance level.
This paper addresses the reliable universal synchronization problem between two coupled chaotic quadratic discrete systems.
Quality assurance in hadrontherapy remains an open issue that can be addressed with reliable monitoring of treatment accuracy.
Since the store-carry-forward delivery manner is adopted for the cooperators to avoid introducing interference to the in-range data communication, a multi-channel collision-free relay mechanism is designed to address the reliable and fast data exchange issue when the vehicular users are outside the service area of the RSU.
Quality control which is an important challenge in present scenario can be addressed with reliable and sensitive quantization of important biological active metabolite in the sample [ 22].
